AI assistant
ARTRYA LIMITED — Capital/Financing Update 2023
Jun 13, 2023
64483_rns_2023-06-13_2650af9e-3d0e-488a-a205-1da1506cd8ff.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [596 x 20] intentionally omitted <==
==> picture [92 x 19] intentionally omitted <==
Coronary Artery Disease. We see you.
ASX ANNOUNCEMENT MARKET RELEASE
14 June 2023
SECONDARY TRADING NOTICE – NOTIFICATION PURSUANT TO PARAGRAPH 708A(5)(E) OF THE CORPORATIONS ACT 2001
Perth, Western Australia - Australian medical device, digital health technology company, Artrya Limited (ASX: AYA) (Artrya or the Company) provides this notice in accordance with section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act) in relation to an issue of 135,000 fully paid ordinary shares by Artrya on 14 June 2023 (Securities).
-
The Securities were issued without disclosure to investors under Part 6D.2 of the Corporations Act.
-
As at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Corporations Act as they apply to the Company and section 674 of the Corporations Act.
-
As at the date of this notice, there is no excluded information (in accordance with the requirements of subsections 708A(7) and (8) of the Corporations Act).
Artrya Limited Kevin Hart Company Secretary
This announcement was approved and authorised for release by the Board of Artrya Limited.
For further information please contact:
Investor Enquiries: Mathew Regan Artrya Limited +61 427 477 298 [email protected]
About Artrya
Based in Perth, Western Australia, Artrya was founded in 2018 and commenced operations in early 2019. Artrya Ltd is listed on the Australian Securities Exchange (ASX: AYA). Artrya is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary artery disease and develop a holistic overview of a patient at risk. Artrya has developed deep learning algorithms that will streamline how medical care for heart disease is delivered. Artrya USA Inc. is a wholly owned subsidiary of Artrya Limited.
For more information, see www.artrya.com
Artrya Limited ACN 624 005 741 1257 Hay Street, West Perth WA 6005 PO Box 567, West Perth WA 6872 www.artrya.com T: +61 8 6478 7816